Intervention

Apixaban 5 MG

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 1 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

1 shown

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanNCT04142658 · 2020-05-01

TERMINATED

Common conditions

Aortic Valve Disease1 Aortic Valve Failure1 Aortic Valve Stenosis1

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

aortic valve disorder1 aortic valve stenosis1

Leading sponsors

Artivion Inc. 1

Trial status mix

TERMINATED1

Phase mix

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.